Rectal swab culture-directed antimicrobial prophylaxis for prostate biopsy and risk of postprocedure infection: A cohort study

Urology

Volumn 85, Issue 1, 2015, Pages 8-14

  Dai, Jessica ^a   Leone, Andrew ^b   Mermel, Leonard ^b   Hwang, Kathleen ^b   Pareek, Gyan ^b   Schiff, Stephen ^b   Golijanin, Dragan ^b   Renzulli, Joseph F ^b  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b RHODE ISLAND HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPICILLIN; ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT; CEFADROXIL; CEFALEXIN; CIPROFLOXACIN; EXTENDED SPECTRUM BETA LACTAMASE; GENTAMICIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; BETA LACTAMASE; QUINOLONE DERIVATIVE;

ADULT; AGED; ANTIBIOTIC PROPHYLAXIS; ANTIBIOTIC RESISTANCE; ANTIGEN SPECIFICITY; BACTERIAL FLORA; CHARLSON COMORBIDITY INDEX; CHI SQUARE TEST; COHORT ANALYSIS; CONFOUNDING VARIABLE; CONTROLLED STUDY; ETHNICITY; FISHER EXACT TEST; HUMAN; INFECTION; INFECTIOUS COMPLICATION; INSTITUTIONAL REVIEW; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; PROSTATE BIOPSY; RECTUM BIOPSY; REVIEW; STATISTICAL ANALYSIS; BACTERIAL INFECTIONS; BIOSYNTHESIS; DRUG EFFECTS; ENZYMOLOGY; GRAM NEGATIVE BACTERIUM; IMAGE GUIDED BIOPSY; INCIDENCE; MICROBIOLOGY; MIDDLE AGED; PATHOLOGY; POSTOPERATIVE COMPLICATIONS; PROCEDURES; PROSTATE; RECTUM; RETROSPECTIVE STUDY; RISK ASSESSMENT;

ANTIBIOTIC PROPHYLAXIS; BACTERIAL INFECTIONS; BETA-LACTAMASES; COHORT STUDIES; DRUG RESISTANCE, BACTERIAL; FLUOROQUINOLONES; GRAM-NEGATIVE BACTERIA; HUMANS; IMAGE-GUIDED BIOPSY; INCIDENCE; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; PROSTATE; RECTUM; RETROSPECTIVE STUDIES; RISK ASSESSMENT;

EID: 84918785295     PISSN: 00904295     EISSN: 15279995     Source Type: Journal    
DOI: 10.1016/j.urology.2014.09.035     Document Type: Article

References (30)

1. S. Loeb, A. Vellekoop, and H.U. Ahmed Systematic review of complications of prostate biopsy Eur Urol 64 2013 876 892
2. D.A. Williamson, L.K. Barrett, and B.A. Rogers Infectious complications following transrectal ultrasound-guided prostate biopsy: new challenges in the era of multidrug-resistant Escherichia coli Clin Infect Dis 57 2013 267 274
3. E.L. Zani, O.A. Clark, and N. Rodrigues Netto Jr. Antibiotic prophylaxis for transrectal prostate biopsy Cochrane Database Syst Rev 2011 CD006576
4. J.S. Wolf Jr., C.J. Bennett, and R.R. Dmochowski Best practice policy statement on urologic surgery antimicrobial prophylaxis J Urol 179 2008 1379 1390
5. F.M. Wagenlehner, E. van Oostrum, and P. Tenke Infective complications after prostate biopsy: outcome of the Global Prevalence Study of Infections in Urology (GPIU) 2010 and 2011, a prospective multinational multicentre prostate biopsy study Eur Urol 63 2013 521 527
6. S. Loeb, H.B. Carter, and S.I. Berndt Complications after prostate biopsy: data from SEER-Medicare J Urol 186 2011 1830 1834
7. R.K. Nam, R. Saskin, and Y. Lee Increasing hospital admission rates for urological complications after transrectal ultrasound guided prostate biopsy J Urol 189 1 Suppl Jan 2013 S12 17 discussion S17-18
8. A. Carignan, J.F. Roussy, and V. Lapointe Increasing risk of infectious complications after transrectal ultrasound-guided prostate biopsies: time to reassess antimicrobial prophylaxis? Eur Urol 62 2012 453 459
9. J. Feliciano, E. Teper, and M. Ferrandino The incidence of fluoroquinolone resistant infections after prostate biopsy-are fluoroquinolones still effective prophylaxis? J Urol 179 2008 952 955 discussion 955
10. G.M. Cannon Jr., M.C. Smaldone, and D.L. Paterson Extended-spectrum beta-lactamase gram-negative sepsis following prostate biopsy: implications for use of fluoroquinolone prophylaxis Can J Urol 14 2007 3653 3655
11. J.P. Horcajada, M. Busto, and S. Grau High prevalence of extended-spectrum beta-lactamase-producing enterobacteriaceae in bacteremia after transrectal ultrasound-guided prostate biopsy: a need for changing preventive protocol Urology 74 2009 1195 1199
12. J.D. Pitout, and K.B. Laupland Extended-spectrum beta-lactamase-producing Enterobacteriaceae: an emerging public-health concern Lancet Infect Dis 8 2008 159 166
13. D. Batura, G.G. Rao, and P.B. Nielsen Prevalence of antimicrobial resistance in intestinal flora of patients undergoing prostatic biopsy: implications for prophylaxis and treatment of infections after biopsy BJU Int 106 2010 1017 1020
14. D. Steensels, K. Slabbaert, and L. De Wever Fluoroquinolone-resistant E. Coli in intestinal flora of patients undergoing transrectal ultrasound-guided prostate biopsy-should we reassess our practices for antibiotic prophylaxis? Clin Microbiol Infect 18 2012 575 581
15. S. Taylor, J. Margolick, and Z. Abughosh Ciprofloxacin resistance in the faecal carriage of patients undergoing transrectal ultrasound guided prostate biopsy BJU Int 111 2013 946 953
16. C. Qi, M. Malczynski, and A.J. Schaeffer Characterization of Ciprofloxacin Resistant Escherichia coli Isolates among Men Undergoing Evaluation for Transrectal Ultrasound Guided Prostate Biopsy J Urol 190 2013 2026 2032
17. C.A. Duplessis, M. Bavaro, and M.P. Simons Rectal cultures before transrectal ultrasound-guided prostate biopsy reduce post-prostatic biopsy infection rates Urology 79 2012 556 561
18. A.K. Taylor, T.R. Zembower, and R.B. Nadler Targeted antimicrobial prophylaxis using rectal swab cultures in men undergoing transrectal ultrasound guided prostate biopsy is associated with reduced incidence of postoperative infectious complications and cost of care J Urol 187 2012 1275 1279
19. N. Suwantarat, D.M. Dumford 3rd, and R. Ponce-Terashima Modification of antimicrobial prophylaxis based on rectal culture results to prevent fluoroquinolone-resistant Escherichia coli infections after prostate biopsy Infect Control Hosp Epidemiol 34 2013 973 976
20. D. Dumford 3rd, N. Suwantarat, and V. Bhasker Outbreak of fluoroquinolone-resistant Escherichia coli infections after transrectal ultrasound-guided biopsy of the prostate Infect Control Hosp Epidemiol 34 2013 269 273
21. M.E. Charlson, P. Pompei, and K.L. Ales A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation J Chronic Dis 40 1987 373 383
22. M.M. Levy, M.P. Fink, and J.C. Marshall 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference Crit Care Med 31 2003 1250 1256
23. E. Ozden, Y. Bostanci, and K.Y. Yakupoglu Incidence of acute prostatitis caused by extended-spectrum beta-lactamase-producing Escherichia coli after transrectal prostate biopsy Urology 74 2009 119 123
24. G. Lorber, S. Benenson, and S. Rosenberg A single dose of 240 mg gentamicin during transrectal prostate biopsy significantly reduces septic complications Urology 82 2013 998 1002
25. M. Adibi, B. Hornberger, and D. Bhat Reduction in hospital admission rates due to post-prostate biopsy infections after augmenting standard antibiotic prophylaxis J Urol 189 2013 535 540
26. R.A. Santucci, and J.N. Krieger Gentamicin for the practicing urologist: review of efficacy, single daily dosing and "switch" therapy J Urol 163 2000 1076 1084
27. M.A. Liss, A. Chang, and R. Santos Prevalence and Significance of Fluoroquinolone Resistant Escherichia coli in Patients Undergoing Transrectal Ultrasound Guided Prostate Needle Biopsy J Urol 185 2011 1283 1288
28. U. Patel, P. Dasgupta, and P. Amoroso Infection after transrectal ultrasonography-guided prostate biopsy: increased relative risks after recent international travel or antibiotic use BJU Int 109 2012 1781 1785
29. D.S. Park, J.J. Oh, and J.H. Lee Simple use of the suppository type povidone-iodine can prevent infectious complications in transrectal ultrasound-guided prostate biopsy Adv Urol 2009 750598
30. M.S. Pearle Should we change our prophylactic antimicrobial regimen for prostate biopsy? J Urol 185 2011 1181 1183